Literature DB >> 23438791

The immune environment of paediatric solid malignancies: evidence from an immunohistochemical study of clinical cases.

John R Apps1, Fyeza Hasan, Oliver Campus, Sam Behjati, Thomas S Jacques, Neil J Sebire, John Anderson.   

Abstract

Childhood malignancies are relatively poorly studied in terms of tumour/host interaction. Using tissue arrays of childhood cancers, we analysed immunohistochemical staining for CD68, CD3 and FOXP3 to evaluate infiltration of myeloid cells, lymphocytes and regulatory T cells. Staining for phosphorylated STAT3 was performed in a subset. The majority of paediatric tumours demonstrated a marked infiltration of CD68+ myeloid cells but, with the exception of neuroblastoma, most showed only sparse infiltration of CD3+/ FOXP3- cells. There was evidence for activation of STAT3 in pPNET (50%), ependymoma (45%) and undifferentiated sarcoma (38%), but it was rarely activated in other tumours.

Entities:  

Mesh:

Year:  2013        PMID: 23438791     DOI: 10.3109/15513815.2012.754527

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  5 in total

Review 1.  Immunotherapy of Neuroblastoma: Facts and Hopes.

Authors:  John Anderson; Robbie G Majzner; Paul M Sondel
Journal:  Clin Cancer Res       Date:  2022-08-02       Impact factor: 13.801

2.  Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

Authors:  Francis Mussai; Sharon Egan; Stuart Hunter; Hannah Webber; Jonathan Fisher; Rachel Wheat; Carmel McConville; Yordan Sbirkov; Kate Wheeler; Gavin Bendle; Kevin Petrie; John Anderson; Louis Chesler; Carmela De Santo
Journal:  Cancer Res       Date:  2015-06-08       Impact factor: 12.701

3.  Catechins and antitumor immunity: Not MDSC's cup of tea.

Authors:  Giorgia Santilli; John Anderson; Adrian J Thrasher; Arturo Sala
Journal:  Oncoimmunology       Date:  2013-05-08       Impact factor: 8.110

Review 4.  Gene and cell therapy for children--new medicines, new challenges?

Authors:  Karen F Buckland; H Bobby Gaspar
Journal:  Adv Drug Deliv Rev       Date:  2014-02-28       Impact factor: 15.470

5.  Immune characterization of pre-clinical murine models of neuroblastoma.

Authors:  Emily R Webb; Silvia Lanati; Carol Wareham; Alistair Easton; Stuart N Dunn; Tatyana Inzhelevskaya; Freja M Sadler; Sonya James; Margaret Ashton-Key; Mark S Cragg; Stephen A Beers; Juliet C Gray
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.